ARA-290 Reference

Plain English

What it is

ARA-290 (also called cibinetide) is a small lab-made peptide based on a piece of erythropoietin, the natural hormone that tells the body to make red blood cells. This version is changed so it does not boost blood cells, and instead aims to calm inflammation and protect tissue. It is not an FDA-approved medicine.

What people use it for

In the research and peptide community, people look at it for nerve pain (neuropathy), inflammation, autoimmune flare-ups, and general recovery. None of these uses are approved or proven, and it is not approved for any condition.

What the science shows

Most of the evidence comes from animal studies that show signals of reduced inflammation and protection of nerves and the heart. A small number of early human trials exist, such as one in nerve damage linked to a disease called sarcoidosis, but the work is still investigational. Longevity and pain-relief claims remain unproven.

The catch

There is no FDA-approved ARA-290 product, so its quality, purity, and safety are not guaranteed and it is still being studied. It is sold as a research chemical, not as medicine, and is not a replacement for proper medical evaluation.

Reference summary

Preclinical studies report tissue-protective, anti-inflammatory, and neuropathic-pain signals; clinical programs remain investigational and indication-specific.

Regulatory and posture

Categories

Recovery, Immune, Longevity

Aliases

Cibinetide, pHBSP, Pyroglutamate helix B surface peptide

Evidence posture

translational - Investigational EPO-derived peptide. Human community use for neuropathy, inflammation, or longevity is not validated by an approved product or broad outcome program.

Regulatory status

No FDA-approved ARA-290 / cibinetide drug label. ClinicalTrials.gov lists investigational studies, including sarcoidosis-associated small-fiber neuropathy. It is not approved for neuropathy, autoimmune disease, longevity, or recovery use.

Content review status

research reference

Related tools

• Injection-site rotation overview - Public overview of the Pro site-rotation planner.
• Protocol builder overview - Public overview of the Pro protocol builder.